A Novel Role for Kruppel-like Factor 14 (KLF14) in T-Regulatory Cell Differentiation

Cellular and Molecular Gastroenterology and Hepatology

Volumn 1, Issue 2, 2015, Pages 188-202.e4

  Sarmento, Olga F ^a   Svingen, Phyllis A ^a   Xiong, Yuning ^a   Xavier, Ramnik J ^b   McGovern, Dermot ^c   Smyrk, Thomas C ^a   Papadakis, Konstantinos A ^a   Urrutia, Raul A ^a   Faubion, William A ^a  

^a MAYO CLINIC   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

FOXP3; H3K9Me3; KLF14; T regulatory cell; TSDR

Indexed keywords

HISTONE METHYLTRANSFERASE; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 14; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; ENHANCER REGION; ENZYME ACTIVATION; EPIGENETICS; EXPERIMENTAL COLITIS; GENE ACTIVATION; GENE REPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SEGREGATION ANALYSIS; T LYMPHOCYTE ACTIVATION;

EID: 84928942078     PISSN: None     EISSN: 2352345X     Source Type: Journal    
DOI: 10.1016/j.jcmgh.2014.12.007     Document Type: Article

References (50)

1. Xiong Y., Khanna S., Grzenda A.L., et al. Polycomb antagonizes p300/CREB-binding protein-associated factor to silence FOXP3 in a Kruppel-like factor-dependent manner. JBiol Chem 2012, 287:34372-34385.
2. Xiong Y., Svingen P.A., Sarmento O.O., et al. Differential coupling of KLF10 to Sin3-HDAC and PCAF regulates the inducibility of the FOXP3 gene. Am J Physiol Regul Integr Comp Physiol 2014, 307:R608-R620.
3. de Assuncao T.M., Lomberk G., Cao S., et al. New role for Kruppel-like factor 14 as a transcriptional activator involved in the generation of signaling lipids. JBiol Chem 2014, 289:15798-15809.
4. Delgoffe G.M., Kole T.P., Zheng Y., et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 2009, 30:832-844.
5. Liu G., Burns S., Huang G., et al. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat Immunol 2009, 10:769-777.
6. reg cells. Nat Immunol 2010, 11:1047-1056.
7. + effector T cell responses. JImmunol 2012, 189:2941-2953.
8. reg-cell function. Nature 2013, 499:485-490.
9. + T cell survival. JImmunol 2010, 184:7247-7256.
10. Nelson J.D., Denisenko O., Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nature Protocols 2006, 1:179-185.
11. Barzaghi F., Passerini L., Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol 2012, 3:211.
12. Okou D.T., Mondal K., Faubion W.A., et al. Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease. JPediatr Gastroenterol Nutr 2014, 58:561-568.
13. + regulatory T cells in the periphery. Gastroenterology 2004, 126:1759-1770.
14. Duijvestein M., Wildenberg M.E., Welling M.M., et al. Pretreatment with interferon-gamma enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells 2011, 29:1549-1558.
15. de Jong Y.P., Abadia-Molina A.C., Satoskar A.R., et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001, 2:1061-1066.
16. Ostanin D.V., Bao J., Koboziev I., et al. Tcell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 2009, 296:G135-G146.
17. Chauhan S.K., Saban D.R., Lee H.K., et al. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. JImmunol 2009, 182:148-153.
18. Wu W., Weigand L., Belkaid Y., et al. Immunomodulatory effects associated with a live vaccine against Leishmania major. Eur J Immunol 2006, 36:3238-3247.
19. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. JExp Med 1994, 179:589-600.
20. Polansky J.K., Kretschmer K., Freyer J., et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008, 38:1654-1663.
21. Baron U., Floess S., Wieczorek G., et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 2007, 37:2378-2389.
22. Chin H.G., Esteve P.-O., Pradhan M., et al. Automethylation of G9a and its implication in wider substrate specificity and HP1 binding. Nucleic Acids Res 2007, 35:7313-7323.
23. Fuks F., Hurd P.J., Deplus R., et al. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 2003, 31:2305-2312.
24. Mathison A., Grzenda A., Lomberk G., et al. Role for Krüppel-like transcription factor 11 in mesenchymal cell function and fibrosis. PLoS One 2013, 8:e75311.
25. Hart G.T., Wang X., Hogquist K.A., et al. Kruppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression. Proc Natl Acad Sci USA 2011, 108:716-721.
26. + T cells. JImmunol 2014, 192:5703-5709.
27. Pabbisetty S.K., Rabacal W., Maseda D., et al. KLF2 is a rate-limiting transcription factor that can be targeted to enhance regulatory T-cell production. Proc Natl Acad Sci USA 2014, 111:9579-9584.
28. Preston G.C., Feijoo-Carnero C., Schurch N., et al. The impact of KLF2 modulation on the transcriptional program and function of CD8 T cells. PLoS One 2013, 8:e77537.
29. Sebzda E., Zou Z., Lee J.S., et al. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat Immunol 2008, 9:292-300.
30. Takada K., Wang X., Hart G.T., et al. Kruppel-like factor 2 is required for trafficking but not quiescence in postactivated T cells. JImmunol 2011, 186:775-783.
31. Weinreich M.A., Takada K., Skon C., et al. KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity 2009, 31:122-130.
32. Winkelmann R., Sandrock L., Kirberg J., et al. KLF2-a negative regulator of pre-B cell clonal expansion and B cell activation. PLoS One 2014, 9:e97953.
33. Winkelmann R., Sandrock L., Porstner M., et al. Bcell homeostasis and plasma cell homing controlled by Kruppel-like factor 2. Proc Natl Acad Sci USA 2011, 108:710-715.
34. - T cells and T regulatory cells. JBiol Chem 2009, 284:24914-24924.
35. + T cells in BALB/c mice by regulating IL-4-generating invariant natural killer T cells. JExp Med 2011, 208:1093-1103.
36. Iwasa T., Nakamura K., Ogino H., et al. Multiple ulcers in the small and large intestines occurred during tocilizumab therapy for rheumatoid arthritis. Endoscopy 2011, 43:70-72.
37. Wildin R.S., Ramsdell F., Peake J., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001, 27:18-20.
38. Bennett C.L., Christie J., Ramsdell F., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20-21.
39. Wildin R.S., Smyk-Pearson S., Filipovich A.H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. JMed Genet 2002, 39:537-545.
40. Humblet-Baron S., Sather B., Anover S., et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. JClin Invest 2007, 117:407-418.
41. Gomez-Rodriguez J., Wohlfert E.A., Handon R., et al. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells. JExp Med 2014, 211:529-543.
42. + regulatory Tcell differentiation by repressing Foxp3 expression. JImmunol 2008, 181:1673-1682.
43. Floess S., Freyer J., Siewert C., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007, 5:e38.
44. Schreiber L., Pietzsch B., Floess S., et al. The Treg-specific demethylated region stabilizes Foxp3 expression independently of NF-κB signaling. PLoS One 2014, 9:e88318.
45. Polansky J.K., Schreiber L., Thelemann C., et al. Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells. JMol Med 2010, 88:1029-1040.
46. + regulatory T cells. Biochem Biophys Res Comm 2010, 400:409-412.
47. Antignano F., Burrows K., Hughes M.R., et al. Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation. JClin Invest 2014, 124:1945-1955.
48. Graler M.H., Huang M.C., Watson S., et al. Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes. JImmunol 2005, 174:1997-2003.
49. Matloubian M., Lo C.G., Cinamon G., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427:355-360.
50. Shiow L.R., Rosen D.B., Brdickova N., et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006, 440:540-544.